Sanofi CEO can’t sugar-coat ‘shocking’ Q2 results

Tracy Staton Call it what you will: chutzpah, optimism, wishful thinking, spin-doctoring, or just plain confidence. In any case, the headline on Sanofi's earnings release–"Last ...

Gist of AstraZeneca’s Q2 results: It could have been worse

Tracy Staton A few high notes in its second-quarter report — notably growth in China and an increase in Brilinta sales–give some support to CEO Pascal Soriot's attempts ...

Seattle Genetics Reports Second Quarter 2013 Financial Results

barbara.lempert -Total Revenues of $ 73.6 Million, Including $ 35.7 Million in ADCETRIS® (Brentuximab Vedotin) Net Product Sales- -Company Executing on Broad ADCETRIS Clinical ...

Pharmacyclics Reports Second Quarter 2013 Results

barbara.lempert SUNNYVALE, Calif., July 31, 2013 /PRNewswire/ — Pharmacyclics, Inc. (the “Company”) (Nasdaq: PCYC) today reported financial results and recent developments ...

Dr. Reddy’s Q1 FY14 Financial Results

barbara.lempert Q1 FY14 Revenues at Rs. 28.4 billion (YoY growth of 12%) Q1 FY14 EBITDA at Rs. 5.7 billion (20% of the revenues, with YoY growth of 13%) Q1 FY14 Adjusted PAT* ...

Pfizer’s 3-way operational split overshadows ‘solid’ Q2 results

Tracy Staton Pfizer dropped a bombshell yesterday, saying it would reorganize into three distinct business units, each with its own group president and financial reports. The thinking, ...

Synta Pharma rebounds on early results from drug study for breast cancer

Ryan McBride FierceBiotech News

InterMune Reports Second Quarter 2013 Financial Results And Business Highlights

barbara.lempert — Reports 7th Consecutive Quarter of Esbriet Revenue Growth–   BRISBANE, Calif., July 24, 2013 /PRNewswire/ — InterMune, Inc. (NASDAQ: ITMN) today ...

Merck reports positive results for lead Alzheimer’s drug

John Carroll FierceBiotech News

WebMD Shares Preliminary 2Q Results

mia.burns WebMD Announces Preliminary Second Quarter Results and Increases Financial Guidance for 2013 NEW YORK, July 12, 2013 /PRNewswire/ — WebMD Health Corp. (NASDAQ: WBMD), ...

Intellipharmaceutics Announces Second Quarter 2013 Results

barbara.lempert TORONTO, July 2, 2013 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, ...

Immunomedics Reports First Results From Phase Ib Study of 90Y-Clivatuzumab

barbara.lempert Immunomedics Reports First Results From Phase Ib Study of 90Y-Clivatuzumab in Patients With Metastatic Pancreatic Cancer After 2 or More Prior Therapies — Repeated ...
Page 4 of 7« First...23456...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS